[Prostate carcinosarcoma.]

Autor: Garde García H; Hospital Central de la Defensa 'Gómez Ulla'. Madrid.España., Hernando Arteche A; Hospital Central de la Defensa 'Gómez Ulla'. Madrid.España., Useros Rodríguez E; Hospital Central de la Defensa 'Gómez Ulla'. Madrid.España., López Galán C; Hospital Central de la Defensa 'Gómez Ulla'. Madrid.España., Paños Fagundo E; Hospital Central de la Defensa 'Gómez Ulla'. Madrid.España., García Murga JC; Hospital Central de la Defensa 'Gómez Ulla'. Madrid.España.
Jazyk: Spanish; Castilian
Zdroj: Archivos espanoles de urologia [Arch Esp Urol] 2018 Sep; Vol. 71 (7), pp. 614-617.
Abstrakt: Objective: To report a new case of prostatic carcinosarcoma, an uncommon and locally and distance aggressive tumor.
Method: We analyzed one case diagnosed in our Center, from clinical and pathological diagnosis to death, describing the treatments received.
Result: Patient presented a huge pelvic mass and a pulmonary metastasis that was treated with cystoprostatectomy and bilateral cutaneous ureterostomy with the diagnosis of carcinosarcoma of the prostate. He received 8 cycles of Docetaxel with bone progression and then 3 cycles of doxorubicin, suspending treatment due to progression. The survival was 18 months.
Conclusions: Prostate carcinosarcoma is a very aggressive neoplasia that does not respond to the usual treatments of prostate cancer.
Databáze: MEDLINE